The discrepancy of the results could be possibly due to the different set of cancers under investigation, as Hongjie et al. (2015) [20] studied the APOA1 levels in renal cell cancer, and their cut off values for APOA1 were quite high and different from our study. This evidence concerns the gene APOA1 and cancer.